Why the study?
This review aimed to inform policymakers and clinical practitioners on evolving global polio epidemiology and scientific advancements to guide eradication strategies, focusing on key developments since January 2019.
Adapting program strategies and focusing on innovations in detection and vaccines are key to achieving and sustaining global polio eradication.
Urges intensified eradication efforts in endemic zones; leaves open optimal strategies amid evolving transmission.
PURPOSE OF REVIEW: Focusing on the key developments since January 2019, this review aims to inform policymakers and clinical practitioners on the latest on evolving global polio epidemiology and scientific advancements to guide strategies for eradication. RECENT FINDINGS: An upsurge in wild poliovirus type 1 cases in Pakistan and Afghanistan and an expansion of type 2 circulating vaccine-derived poliovirus transmission in multiple countries threaten the remarkable progress made over past several decades by the global eradication program. These challenges have also spurred innovation on multiple fronts, including earlier detection, enhanced environmental surveillance and safer and more affordable vaccine options. SUMMARY: A concerted effort to adapt program strategies to address context-specific challenges and continued focus on innovations to enhance detection and response capabilities will be the key to achieve and sustain eradication of all types of polioviruses.
No takes yet. Share an insight, caveat, or question.
Bandyopadhyay et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: